Alphabet’s Life Sciences Arm granted the staff and eliminated his entire device program on Monday. CEO Stephen Gillett announced the “difficult decision” for the program in one Staff memoAccording to Business Insider. “Over the years, Verily has built up an inheritance in the development of innovative medical devices of world class,” Gillett wrote and noted […]
